Thomas C. VanCott

Advanced BioScience Laboratories, Inc. provides contract manufacturing and laboratory research services to advance leading vaccines and therapies from clinical development to the commercial market. It focuses on the development of therapeutics, vaccines, and other biologic products. The company was founded in 1961 and is headquartered in Rockville, MD.

Excellos, Inc. is a full-service contract development and manufacturing organization (CDMO) based in San Diego, CA. Excellos is focused on supplying cGMP cellular products and services, as well as process development and manufacturing expertise to scientists and clinicians working with cell and gene therapies. The company is dedicated to improving human life by providing critical products and services to life science research and the next generation of cell and gene therapies. Excellos accelerates cell and gene therapies by improving the quality, breadth, and variance of donor samples, and providing end-to-end cell therapy services. The company's proprietary Excellos 360 technology provides deep characterization of cells to better match patient with therapeutic development needs. The company was founded in 2020 and is led by CEO David Wellis.

Advanced BioScience Laboratories, Inc. provides contract manufacturing and laboratory research services to advance leading vaccines and therapies from clinical development to the commercial market. It focuses on the development of therapeutics, vaccines, and other biologic products. The company was founded in 1961 and is headquartered in Rockville, MD.

Excellos, Inc. is a full-service contract development and manufacturing organization (CDMO) based in San Diego, CA. Excellos is focused on supplying cGMP cellular products and services, as well as process development and manufacturing expertise to scientists and clinicians working with cell and gene therapies. The company is dedicated to improving human life by providing critical products and services to life science research and the next generation of cell and gene therapies. Excellos accelerates cell and gene therapies by improving the quality, breadth, and variance of donor samples, and providing end-to-end cell therapy services. The company's proprietary Excellos 360 technology provides deep characterization of cells to better match patient with therapeutic development needs. The company was founded in 2020 and is led by CEO David Wellis.

Excellos, Inc. is a full-service contract development and manufacturing organization (CDMO) based in San Diego, CA. Excellos is focused on supplying cGMP cellular products and services, as well as process development and manufacturing expertise to scientists and clinicians working with cell and gene therapies. The company is dedicated to improving human life by providing critical products and services to life science research and the next generation of cell and gene therapies. Excellos accelerates cell and gene therapies by improving the quality, breadth, and variance of donor samples, and providing end-to-end cell therapy services. The company's proprietary Excellos 360 technology provides deep characterization of cells to better match patient with therapeutic development needs. The company was founded in 2020 and is led by CEO David Wellis.